(File Photo: VCG)

In order to discover and eliminate risks in vaccine production in a timely way, the China Food and Drug Administration sent 45 inspection teams from July 23 to August 9 to conduct comprehensive and thorough risk investigations in all 45 vaccine manufacturers in China excluding Changchun Changsheng Life Sciences Limited, which is being investigated separately. 

The investigation showed that the existing vaccines were produced normally in accordance with the standards in the Good Manufacture Practice of Medical Products regulations and no problems affecting the quality and safety of the vaccine have been found.